Creative Biolabs Offers Innovative Solutions to Expedite World Immunotherapy Development
New York, USA – February 21, 2023 – In recent years, immunotherapy has been studied extensively as a promising cancer treatment that can assist the immune system in combating cancer and other diseases. Embracing the fast progress of immunotherapy development, Creative Biolabs is now providing different immunotherapy development services to facilitate customer projects, including immune checkpoint drug development, macrophage therapeutics, and cell therapy services.
“To better support the fast growth of immunotherapy development, we have optimized our technical pipeline in immune checkpoint antibody development,” according to an expert at Creative Biolabs.
Creative Biolabs provides a comprehensive service portfolio, including but not limited to discovery and development, characterization, engineering, and optimization of immune checkpoint antibodies, dedicated to serving customers with high-standard immune checkpoint antibody development services based on the world’s leading technology platforms.
In addition, macrophage therapeutics, another promising immunotherapy strategy, is being extensively researched. With a focus on providing superior service and innovation, scientists from Creative Biolabs have unveiled professional consulting strategies and custom solutions to better proceed with customer projects in macrophage therapeutics. A dedicated scientific and technical team from the company is available to address any technical issues, making sure all projects are on track.
Macrophage therapeutic services provided at Creative Biolabs include but are not limited to macrophage polarization phenotype identification and characterization services, macrophage reprogramming services, and macrophage-targeted drug delivery system development.
Furthermore, natural killer cells for immunotherapy development have provided a new avenue for cell-based immunotherapy due to their distinctive features of rapid killing and broad cytotoxicity.
“Natural killer cell-based immunotherapy has brought great hope for cancer treatment in the past year,” commented the scientist, “but challenges remain that require ongoing research and innovative solutions to make breakthroughs.”
With extensive experience in immunotherapy development, Creative Biolabs is confident in its capacity to offer strong, risk-based preclinical data verification services for natural killer cell-based immunotherapy.
To learn more about services applied to immunotherapy development at Creative Biolabs, please visit https://macrophage.creative-biolabs.com.
About Creative Biolabs
Creative Biolabs, as an industry-leading service provider, is committed to providing integrated solutions and advancing global immunotherapy development. With thousands of researchers and companies benefiting from well-rounded immunotherapy development services that enabled breakthrough discoveries, Creative Biolabs continues to provide access to comprehensive and high-quality immunotherapy services, backed by a dedicated expert team and cutting-edge technology platforms.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://macrophage.creative-biolabs.com
